{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-22-000010","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2022-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.541935+00:00","generated_at":"2026-06-26T10:12:03.724760+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"West Pharma amends credit facility to $500M, extends to 2027; adds Japanese subsidiary as borrower","bullets":["Increased credit facility from $300M to $500M senior unsecured revolving; maturity extended to March 31, 2027.","Added West Pharmaceutical Services Holding Japan Godo Kaisha as additional borrower under the facility.","Interest: Term SOFR + 0.10% + margin of 87.5-137.5 bps or base rate + 0-37.5 bps.","Financial covenant: Net Consolidated Debt to modified EBITDA ratio max 3.5:1 (4.0:1 for qualified acquisitions up to 4 quarters)."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-22-000010","json":"https://secwatch.observer/filing/0000105770-22-000010.json","markdown":"https://secwatch.observer/filing/0000105770-22-000010.md","text":"https://secwatch.observer/filing/0000105770-22-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577022000010/0000105770-22-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577022000010/wst-20220331.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T10:12:03.724760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}